ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sutro, Celgene to Refocus 2014 Immuno-Oncology Collaboration
americanpharmaceuticalreview
August 11, 2017Sutro Biopharma announced it is refocusing its 2014 immuno-oncology collaboration with Celgene on four programs that are advancing through preclinical development, including an antibody drug conjugate (ADC) program targeting B-Cell maturation antigen (BCM
Pharma Sources Insight January 2025
